India gives Hetero Labs and Cipla approval to make Gilead’s COVID-19 drug

(Reuters) – India’s drug regulator has given Hetero Labs the green light to manufacture and market its generic version of Gilead Science’s experimental COVID-19 treatment remdesivir, the Indian pharm…
Read More